LCR10 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

The LCR10 antibody is a monoclonal antibody with applications in both prophylaxis and therapy against Staphylococcus aureus pneumonia . Additionally, the 1B1.3A monoclonal antibody reacts with mouse CD210, which is also known as the IL-10 receptor . CD210 is a member of the interferon receptor-like family that is expressed on a variety of hematopoietic cells, including thymocytes, T cells, B cells, NK cells, monocytes, and macrophages .

LCR10 in Staphylococcus aureus Pneumonia

  • Efficacy: Studies have demonstrated that LCR10 prophylaxis leads to improved survival rates and a reduction in the hyperinflammatory response and lung damage associated with S. aureus pneumonia in mice . Passive immunization with LC10 increased survival and reduced bacterial numbers in the lungs and kidneys of infected mice and showed protection against diverse S. aureus clinical isolates .

  • Mechanism of Action: LCR10 functions by neutralizing alpha-toxin (AT), a key virulence factor of S. aureus . The lungs of S. aureus-infected mice exhibited bacterial pneumonia, including widespread inflammation, whereas the lungs of mice that received LC10 exhibited minimal inflammation and retained healthy architecture . Consistent with reduced immune cell infiltration, LC10-treated animals had significantly lower proinflammatory cytokine and chemokine levels in the bronchoalveolar lavage fluid than did those of the control animals . This reduction in inflammation and damage to the LC10-treated animals resulted in reduced vascular protein leakage and CO2 levels in the blood .

  • Therapeutic Potential: LCR10 has been assessed for its therapeutic activity in combination with vancomycin or linezolid . Treatment with a combination of LC10 and vancomycin or linezolid resulted in a significant increase in survival relative to the monotherapies and was deemed additive to synergistic by isobologram analysis . Consistent with improved survival, the lungs of animals treated with antibiotic plus LC10 exhibited less inflammatory tissue damage than those that received monotherapy .

CD210 (IL-10R)

  • Expression: CD210 is expressed on a variety of hematopoietic cells, including thymocytes, T cells, B cells, NK cells, monocytes, and macrophages .

  • Function: Binding of IL-10 to its receptor initiates JAK/STAT signaling that leads to B cell proliferation and inhibition of macrophage activation . The protein encoded by this gene is a receptor for interleukin 10 . This protein is structurally related to interferon receptors . It has been shown to mediate the immunosuppressive signal of interleukin 10, and thus inhibits the synthesis of proinflammatory cytokines . This receptor is reported to promote survival of progenitor myeloid cells through the insulin receptor substrate-2/PI 3-kinase/AKT pathway . Activation of this receptor leads to tyrosine phosphorylation of JAK1 and TYK2 kinases .

  • Applications: The 1B1.3A antibody has been reported for use in functional assays . The 1B1.3A antibody has been reported to have neutralizing activity .

Characteristics

CharacteristicDetail
ReactivityMouse CD210 (IL-10 receptor)
Cell TypesThymocytes, T cells, B cells, NK cells, monocytes, macrophages
FunctionInitiates JAK/STAT signaling, mediates immunosuppression
ApplicationsFunctional assays
PurityGreater than 90%, as determined by SDS-PAGE
Endotoxin LevelLess than 0.001 ng/µg antibody, as determined by LAL assay
AggregationLess than 10%, as determined by HPLC
Filtration0.2 µm post-manufacturing filtered

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
LCR10 antibody; At2g15535 antibody; F9O13 antibody; Defensin-like protein 144 antibody; Low-molecular-weight cysteine-rich protein 10 antibody; Protein LCR10 antibody
Target Names
LCR10
Uniprot No.

Target Background

Database Links

KEGG: ath:AT2G15535

STRING: 3702.AT2G15535.1

UniGene: At.40394

Protein Families
DEFL family
Subcellular Location
Secreted.

Q&A

What is the structural significance of the LCR10 antibody in molecular biology?

The LCR10 antibody is a monoclonal antibody that targets specific epitopes within low-complexity regions (LCRs) of proteins. LCRs are often characterized by repetitive sequences or homopolymeric stretches that play critical roles in protein-protein interactions, cellular signaling, and structural organization. The specificity of LCR10 for these regions makes it a valuable tool for probing molecular mechanisms in various biological systems .

Studies have shown that antibodies targeting LCRs can influence the folding, stability, and aggregation properties of proteins. For example, the use of monoclonal antibodies like LCR10 has been instrumental in elucidating the structural dynamics of viral proteins during infection cycles . Additionally, its application extends to understanding genomic "accordion" phenomena where repetitive sequences undergo expansion and contraction . This structural insight is critical for designing experiments aimed at understanding protein function at both cellular and systemic levels.

How can I optimize experimental conditions when using the LCR10 antibody in immunofluorescence assays?

Immunofluorescence assays require precise optimization to ensure accurate detection and quantification of target antigens. When using the LCR10 antibody, several factors must be considered:

  • Antibody Concentration: The optimal dilution ratio should be determined empirically based on preliminary titration experiments. Typically, starting concentrations range from 1:100 to 1:500 depending on the antigen's abundance .

  • Fixation Protocols: Fixation methods such as paraformaldehyde or methanol can affect epitope accessibility. For LCR-rich targets, paraformaldehyde fixation followed by permeabilization with Triton X-100 is recommended to preserve protein integrity while allowing antibody access .

  • Blocking Agents: Non-specific binding can be minimized using blocking agents like bovine serum albumin (BSA) or casein. These agents prevent background fluorescence and enhance signal specificity .

  • Secondary Antibody Selection: Fluorophore-conjugated secondary antibodies should match the host species of LCR10 (e.g., anti-mouse or anti-rat). Fluorescence spectra should be chosen based on available imaging equipment to avoid spectral overlap .

  • Imaging Parameters: High-resolution confocal microscopy or super-resolution techniques are preferred for visualizing LCR-targeted interactions due to their ability to resolve fine structural details .

By systematically optimizing these parameters, researchers can achieve reproducible results that accurately reflect the spatial distribution and abundance of LCRs within cellular environments.

What are common challenges in interpreting data from experiments involving the LCR10 antibody?

Researchers often encounter challenges when working with antibodies targeting low-complexity regions due to their unique biochemical properties:

  • Epitope Accessibility: Low-complexity regions may be buried within protein structures or occluded by interacting molecules, making them less accessible to antibodies like LCR10 during certain experimental conditions .

  • Cross-Reactivity: Due to the repetitive nature of LCRs, antibodies may exhibit cross-reactivity with structurally similar sequences in non-target proteins, leading to false-positive results .

  • Aggregation Artifacts: Proteins containing LCRs are prone to aggregation under physiological conditions, which can complicate data interpretation in assays such as Western blotting or immunoprecipitation .

  • Signal Variability: Variability in signal intensity across replicates may arise from differences in sample preparation, antibody quality, or imaging settings .

To address these challenges, researchers should employ rigorous controls (e.g., isotype controls), validate findings using complementary techniques (e.g., mass spectrometry), and perform statistical analyses to ensure data reliability.

How does the LCR10 antibody contribute to understanding genomic variability?

For example, genomic studies using high-resolution sequencing have revealed that variations within LCRs are associated with phenotypic differences among viral strains or subclades . The ability of LCR10 to bind specifically to these regions enables researchers to map their distribution and investigate their functional implications.

Furthermore, experiments employing LCR-targeting antibodies have demonstrated that changes in repeat length within these regions can influence gene expression patterns, protein stability, and evolutionary adaptability . This has profound implications for understanding diseases caused by pathogens with high genomic plasticity.

What experimental designs are suitable for studying protein-protein interactions mediated by low-complexity regions using the LCR10 antibody?

Protein-protein interactions involving low-complexity regions can be studied using several experimental approaches:

  • Co-Immunoprecipitation (Co-IP): Co-IP assays allow researchers to isolate protein complexes containing LCRs by using the LCR10 antibody as a bait molecule. This technique is particularly useful for identifying novel interaction partners within cellular lysates .

  • Surface Plasmon Resonance (SPR): SPR provides quantitative data on binding kinetics between proteins containing low-complexity regions and their interacting partners. The immobilization of target proteins on SPR chips coated with the LCR10 antibody enables real-time monitoring of interaction dynamics .

  • Fluorescence Resonance Energy Transfer (FRET): FRET-based assays can visualize spatial proximity between interacting proteins tagged with fluorescent probes when mediated by low-complexity regions recognized by LCR10 .

  • Optical Tweezers: This technique measures forces involved in molecular interactions at single-molecule resolution. Optical tweezers have been successfully used to study receptor-ligand interactions involving antibodies like LCR10 on cell surfaces .

By employing these methodologies, researchers can gain insights into how low-complexity regions mediate critical biological processes such as signaling cascades or structural assembly.

How does salt concentration affect antigen-antibody binding when using the LCR10 antibody?

Salt concentration plays a crucial role in modulating antigen-antibody interactions due to its impact on electrostatic forces and hydrophobic effects:

Experimental studies have demonstrated that optimizing salt concentration is essential for achieving reliable results when working with antibodies targeting low-complexity regions like those recognized by LCR10 . Researchers should perform titration experiments across a range of salt concentrations to identify conditions that maximize specificity without compromising sensitivity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.